FARP1-AS1

Across TCGA pan-cancer cohorts, FARP1-AS1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of FARP1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where FARP1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FARP1-AS1 is over-expressed in tumor, although a few such as KIRC and HNSC show the opposite, repressed pattern.

UCEC, BRCA, and COAD are the cancer types where FARP1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FARP1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.610	.002	6	view →
BRCA	Female	All	+0.208	.001	6	view →
COAD	Female	II,III,IV	+0.838	<.001	5	view →
KIRC	Male	IV	−0.227	<.001	5	view →
LIHC	All	All	+0.138	.004	5	view →
CHOL	Male	All	+0.856	.008	2	view →
STAD	All	II,III,IV	+0.271	.022	2	view →
HNSC	All	IV	−0.215	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

FARP1-AS1–UCEC

Open the UCEC breakdown →